Exscientia Enters Four-Year Collaboration for Development of Antiviral Therapeutics

Exscientia has entered into a four-year agreement with the Bill & Melinda Gates Foundation for the development of small-molecule therapeutics that can tackle coronavirus and other viruses with pandemic potential.